在帕金森氏症患者的日常职业表现 (CO-OP) 的认知导向:随机试验结果
概括
这项研究探讨了帕金森病 (PwPD) 患者的日常职业表现 (CO-OP) 的认知导向. 合作证明是可行的,并可能有利于改善普华永道的日常运作.
科学领域:
- 神经康复疗法 神经康复疗法
- 职业疗法 职业疗法 职业疗法
- 临床试验 临床试验
背景情况:
- 帕金森病 (PwPD) 会导致逐渐增长的残疾,影响运动和非运动功能.
- 综合性康复对于最大限度地提高PwPD的日常功能至关重要.
- 对日常职业绩效的认知导向 (CO-OP) 是一种有针对性的方法,在类似的条件下已被证明有效.
研究的目的:
- 评估CO-OP对帕金森病患者的可行性和潜在益处.
- 一个随机对照试验 (RCT) 旨在探索CO-OP在PwPD中的适用性.
- 调查CO-OP对实现目标,功能状态和生活质量的影响.
主要方法:
- 一个平行组,评估者蒙面的RCT涉及20名PwPD.
- 参与者被随机分配到CO-OP干预 (10周的20次会议) 或等候名单控制 (WLC) 中.
- 结果措施包括目标实现,功能和认知状态,生活质量,自我效能,转移和维护.
主要成果:
- 努力和乐趣的高评分,以及强烈完成家庭作业 (91%) 和遵守协议 (82%),表明CO-OP的可行性.
- 在加拿大职业绩效衡量 (COPM) 绩效和满意度以及绩效质量评级表 (PQRS) 中,CO-OP显著超过了WLC.
- 在目标实现量表 (GAS) 上,组之间没有发现显著差异.
结论:
- 合作社是可实施的,可行的,并显示了对帕金森病患者的潜在益处.
- 这些发现解决了帕金森病管理策略中的重大差距.
- 建议进行进一步的研究,以确定CO-OP对PwPD的有效性.
关键词:
爱尔戈疗法 (Ergothérapie) 是一种工作疗法.超认知策略培训 超认知策略培训神经康复疗法 神经康复疗法职业治疗是一种职业疗法.形成一个战略的metacognitive.神经系统的适应.更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.7K
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.0K
相关概念视频
Parkinson's Disease: Treatment
166
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
